Abstract
Targeted ultrasound contrast microbubble materials are designed as hollow micron-size spheres with a biocompatible shell stabilizer. Excellent detection sensitivity of these particles (down to individual particles of a picogram mass) is achieved routinely with clinical ultrasound. To improve stability and in vivo circulation time, poorly soluble perfluorinated gases can be used as the particle core. Microbubble shell (from several to several hundred nanometers thick) can be made of protein, polymer, lipid, surfactant, or combinations of these. Targeting ligands (antibodies, peptides and mimetics, carbohydrates and combinations) can be attached to the shell, either directly or via a protein/polymer spacer arm. To improve targeting in fast flow conditions that are characterized by high wall shear stress, microbubbles can be outfitted with surface folds/microvilli. Alternatively, bio-inspired fastbinding ligands, such as peptides from P-selectin Glycoprotein Ligand-1 or sialyl Lewis carbohydrates can be applied.
Selective targeting of the microbubbles to the vascular markers of diseases was successful in multiple animal model studies. Selectins, integrins, or addressins on vascular endothelium surface that are upregulated in response to inflammation or ischemia-reperfusion injury have been targeted successfully, ultrasound contrast enhancement of target tissues achieved. Angiogenic endothelium in the tumor vasculature has been imaged by targeting microbubbles to αvβ3 and similar molecules. Overall, the convenience, low cost, and real-time capabilities of ultrasound imaging, combined with molecular imaging capabilities of targeted microbubble contrast agents, may offer significant improvement in patient diagnostics and treatment progress monitoring.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Albrecht, T., Blomley, M.J.K., Heckemann, R.A., Cosgrove, D.O., Jayaram, V., Butler-Barnes, J., Eckersley, R.J., Hoffmann, C.W., Bauer, A., 2000. Stimulated acoustic emission with the ultrasound contrast agent levovist: a clinically useful contrast effect with liver-specific properties. Rofo-Fortschritte Auf Dem Gebiet Der Rontgenstrahlen Und Der Bildgebenden Verfahren 172, 61–67.
AlkanOnyuksel, H., Demos, S.M., Lanza, G.M., Vonesh, M.J., Klegerman, M.E., Kane, B.J., Kuszak, J., McPherson, D.D., 1996. Development of inherently echogenic liposomes as an ultrasonic contrast agent. J Pharm Sci 85, 486–490.
Bachmann, C., Klibanov, A.L., Olson, T.S., Sonnenschein, J.R., Rivera-Nieves, J., Cominelli, F., Ley, K.F., Lindner, J.R., Pizarro, T.T., 2006. Targeting mucosal addressin cellular adhesion molecule (MAdCAM)-1 to noninvasively image experimental Crohn’s disease. Gastroenterology 130, 8–16.
Bloch, S.H., Short, R.E., Ferrara, K.W., Wisner, E.R., 2005. The effect of size on the acoustic response of polymer-shelled contrast agents. Ultrasound in Medicine and Biology 31, 439–444.
Bouakaz, A., Versluis, M., de Jong, N., 2005. High-speed optical observations of contrast agent destruction. Ultrasound in Medicine and Biology 31, 391–399.
Chomas, J.E., Dayton, P.A., May, D., Allen, J., Klibanov, A., Ferrara, K., 2000. Optical observation of contrast agent destruction. Applied Physics Letters 77, 1056–1058.
Christiansen, J.P., Leong-Poi, H., Klibanov, A.L., Kaul, S., Lindner, J.R., 2002. Noninvasive imaging of myocardial reperfusion injury using leukocyte-targeted contrast echocardiography. Circulation 105, 1764–1767.
Christiansen, J.P., Song, J., Matsunaga, T., Lindner, J.R., 2001. Microbubbles targeted to the platelet IIb/IIIa integrin adhere to microvascular thrombi in-vivo. Circulation 104, 589–589.
Dayton, P.A., Chomas, J.E., Lum, A.F.H., Allen, J.S., Lindner, J.R., Simon, S.I., Ferrara, K.W., 2001. Optical and acoustical dynamics of microbubble contrast agents inside neutrophils. Biophys J 80, 1547–1556.
Dienst, A., Grunow, A., Unruh, M., Rabausch, B., Nor, J.E., Fries, J.W.U., Gottstein, C., 2005. Specific occlusion of murine and human tumor vasculature by VCAM-1-targeted recombinant fusion proteins. J Natl Cancer Inst 97, 733–747.
Ellegala, D.B., Poi, H.L., Carpenter, J.E., Klibanov, A.L., Kaul, S., Shaffrey, M.E., Sklenar, J., Lindner, J.R., 2003. Imaging tumor angiogenesis with contrast ultrasound and microbubbles targeted to alpha(v)beta(3). Circulation 108, 336–341.
Eniola, A.O., Willcox, P.J., Hammer, D.A., 2003. Interplay between rolling and firm adhesion elucidated with a cell-free system engineered with two distinct receptor-ligand pairs. Biophys J 85, 2720–2731.
Fadok, V.A., Chimini, G., 2001. The phagocytosis of apoptotic cells. Semin Immunol 13, 365–372.
Fritz, T.A., Unger, E.C., Sutherland, G., Sahn, D., 1997. Phase I clinical trials of MRX115. A new ultrasound contrast agent. Invest Radiol 32, 735–740.
Grinstaff, M.W., Suslick, K.S., 1991. Air-Filled Proteinaceous Microbubbles – Synthesis of an Echo-Contrast Agent. Proc Natl Acad Sci U S A 88, 7708–7710.
Hauff, P., Reinhardt, M., Briel, A., Debus, N., Schirner, M., 2004. Molecular targeting of lymph nodes with L-selectin ligand-specific US contrast agent: A feasibility study in mice and dogs. Radiology 231, 667–673.
Hermanson, G.T., 1996. Bioconjugate techniques. Academic Press, San Diego.
Hvattum, E., Uran, S., Sandbaek, A.G., Karlsson, A.A., Skotland, T., 2006. Quantification of phosphatidylserine, phosphatidic acid and free fatty acids in an ultrasound contrast agent by normal-phase high-performance liquid chromatography with evaporative light scattering detection. J Pharm Biomed Anal 42, 506–512.
Jeppesen, C., Wong, J.Y., Kuhl, T.L., Israelachvili, J.N., Mullah, N., Zalipsky, S., Marques, C.M., 2001. Impact of polymer tether length on multiple ligand-receptor bond formation. Science 293, 465–468.
Jordan, J.E., Zhao, Z.Q., Vinten-Johansen, J., 1999. The role of neutrophils in myocardial ischemia-reperfusion injury. Cardiovasc Res 43, 860–878.
Keller, M.W., Glasheen, W., Kaul, S., 1989. Albunex: a safe and effective commercially produced agent for myocardial contrast echocardiography. J Am Soc Echocardiogr 2, 48–52.
Kim, D.H., Klibanov, A.L., Needham, D., 2000. The influence of tiered layers of surface-grafted poly(ethylene glycol) on receptor-ligand-mediated adhesion between phospholipid monolayer-stabilized microbubbles and coated class beads. Langmuir 16, 2808–2817.
Klibanov, A.L., Gu, H., J.K. Wojdyla, Jr., J.H.W., Kim, D.H., Needham, D., Villanueva, F.S., Brandenburger, G.H., 1999. Attachment of ligands onto the gas-filled microbubbles via PEG spacer arm and lipid residues anchored at the interface., Proceedings of 26th International Symposium on Controlled Release of Bioactive Materials, Boston. Controlled Release Society, pp. 124–125.
Klibanov, A.L., Hughes, M.S., Marsh, J.N., Hall, C.S., Miller, J.G., Wible, J.H., Brandenburger, G.H., 1997. Targeting of ultrasound contrast material -An in vitro feasibility study. Acta Radiologica 38, 113–120.
Klibanov, A.L., Hughes, M.S., Wojdyla, J.K., Marsh, J.N., Hall, C.S., Miller, J.G., Wible, J.H., Brandenburger, G.H., 1998. Targeting of ultrasound contrast material: Selective imaging of microbubbles in vitro. Acad Radiol 5, S243–S246.
Klibanov, A.L., Maruyama, K., Beckerleg, A.M., Torchilin, V.P., Huang, L., 1991. Activity of Amphipathic Poly(Ethylene Glycol)-5000 to prolong the circulation time of liposomes depends on the liposome size and is unfavorable for immunoliposome binding to target. Biochimica Et Biophysica Acta 1062, 142–148.
Klibanov, A.L., Rasche, P.T., Hughes, M.S., Wojdyla, J.K., Galen, K.P., Wible, J.H., Brandenburger, G.H., 2002. Detection of individual microbubbles of an ultrasound contrast agent: Fundamental and pulse inversion imaging. Acad Radiol 9, S279–S281.
Klibanov, A.L., Rasche, P.T., Hughes, M.S., Wojdyla, J.K., Galen, K.P., Wible, J.H., Brandenburger, G.H., 2004. Detection of individual microbubbles of ultrasound contrast agents – Imaging of free-floating and targeted bubbles. Invest Radiol 39, 187–195.
Klibanov, A.L., Rychak, J.J., Yang, W.C., Li, B., Acton, S., Lindner, J.R., Ley, K.F., Kaul, S., 2006. Targeted ultrasound contrast agents for molecular imaging in high-shear flow. Contrast Media & Molecular Imaging 1, 259–266.
Kremkau, F.W., 2002. Diagnostic Ultrasound: Principles and Instruments, 7th ed. Elsevier Health Sciences, NY.
Lanza, G.M., Abendschein, D.R., Hall, C.S., Scott, M.J., Scherrer, D.E., Houseman, A., Miller, J.G., Wickline, S.A., 2000. In vivo molecular imaging of stretch-induced tissue factor in carotid arteries with ligand-targeted nanoparticles. J Am Soc Echocardiogr 13, 608–614.
Lee, R.J., Low, P.S., 1995. Folate-mediated tumor-cell targeting of liposome-entrapped doxorubicin in-vitro. Biochimica Et Biophysica Acta-Biomembranes 1233, 134–144.
Leighton, T., 1994. The acoustic bubble. Academic Press, NY.
Leong-Poi, H., Christiansen, J., Heppner, P., Lewis, C.W., Klibanov, A.L., Kaul, S., Lindner, J.R., 2005. Assessment of endogenous and therapeutic arteriogenesis by contrast ultrasound molecular Imaging of integrin expression. Circulation 111, 3248–3254.
Leong-Poi, H., Christiansen, J., Klibanov, A.L., Kaul, S., Lindner, J.R., 2003. Noninvasive assessment of angiogenesis by ultrasound and microbubbles targeted to alpha(v)integrins. Circulation 107, 455–460.
Ley, K., 1992. Leukocyte Adhesion to Vascular Endothelium. J Reconstr Microsurg 8, 495–503.
Lindner, J.R., Song, J., Christiansen, J., Klibanov, A.L., Xu, F., Ley, K., 2001. Ultrasound assessment of inflammation and renal tissue injury with microbubbles targeted to P-selectin. Circulation 104, 2107–2112.
Lindner, J.R., Song, J., Xu, F., Klibanov, A.L., Singbartl, K., Ley, K., Kaul, S., 2000. Noninvasive ultrasound imaging of inflammation using microbubbles targeted to activated leukocytes. Circulation 102, 2745–2750.
Linker, R.A., Reinhardt, M., Bendszus, M., Ladewig, G., Briel, A., Schirner, M., Maurer, M., Hauff, P., 2005. In vivo molecular imaging of adhesion molecules in experimental autoimmune encephalomyelitis (EAE). J Autoimmun 25, 199–205.
Lu, E.X., Wagner, W.R., Schellenberger, U., Abraham, J.A., Klibanov, A.L., Woulfe, S.R., Csikari, M.M., Fischer, D., Schreiner, G.F., Brandenburger, G.H., Villanueva, F.S., 2003. Targeted in vivo labeling of receptors for vascular endothelial growth factor – Approach to identification of ischemic tissue. Circulation 108, 97–103.
McEver, R.P., 1997. Selectin-carbohydrate interactions during inflammation and metastasis. Glycoconj J 14, 585–591.
Narayan, P.M., Marchant, D., Wheatley, M.A., 2001. Optimization of spray drying by factorial design for production of hollow microspheres for ultrasound imaging. J Biomed Mater Res 56, 333–341.
Narayan, P., Wheatley, M.A., 1999. Preparation and characterization of hollow microcapsules for use as ultrasound contrast agents. Polym Eng Sci 39, 2242–2255.
Park, E.Y.H., Smith, M.J., Stropp, E.S., Snapp, K.R., DiVietro, J.A., Walker, W.F., Schmidtke, D.W., Diamond, S.L., Lawrence, M.B., 2002. Comparison of PSGL-1 microbead and neutrophil rolling: microvillus elongation stabilizes P-selectin bond clusters. Biophys J 82, 1835–1847.
Porter, T.R., Xie, F., 1995. Transient Myocardial Contrast after Initial Exposure to Diagnostic Ultrasound Pressures with Minute Doses of Intravenously Injected Microbubbles – Demonstration and Potential Mechanisms. Circulation 92, 2391–2395.
Rychak, J.J., Klibanov, A.L., Leppanen, A., Cummings, R.D., Ley, K., 2004. Enhanced binding of ultrasound contrast microbubbles targeted to P-selectin using a physiological capture ligand. Faseb J 18, A446–A446.
Rychak, J.J., Lindner, J.R., Ley, K., Klibanov, A.L., 2006. Deformable gas-filled microbubbles targeted to P-selectin. J Control Release 114, 288–299.
Schneider, M., 1999. Characteristics of SonoVue (TM). Echocardiography-a J Cardiovasc Ultrasound and Allied Tech 16, 743–746.
Straub, J.A., Chickering, D.E., Church, C.C., Shah, B., Hanlon, T., Bernstein, H., 2005. Porous PLGA microparticles: AI-700, an intravenously administered ultrasound contrast agent for use in echocardiography. J Control Release 108, 21–32.
Toublan, F.J.J., Boppart, S., Suslick, K.S., 2006. Tumor targeting by surface-modified protein microspheres. J Am Chem Soc 128, 3472–3473.
Unger, E.C., McCreery, T.P., Sweitzer, R.H., Shen, D.K., Wu, G.L., 1998. In vitro studies of a new thrombus-specific ultrasound contrast agent. Am J Cardiol 81, 58g–61g.
Villanueva, F.S., Jankowski, R.J., Klibanov, S., Pina, M.L., Alber, S.M., Watkins, S.C., Brandenburger, G.H., Wagner, W.R., 1998. Microbubbles targeted to intercellular adhesion molecule-1 bind to activated coronary artery endothelial cells. Circulation 98, 1–5.
Vonbibra, H., Hartmann, F., Petrik, M., Schlief, R., Renner, U., Blomer, H., 1989. Contrast Color-Coded Doppler Flow Imaging -Improved Diagnosis of Right Heart-Disease after Intravenous-Injection of Echovist. Zeitschrift Fur Kardiologie 78, 101–108.
Watanabe, R., Matsumura, M., Chen, C.J., Kaneda, Y., Fujimaki, M., 2005. Characterization of tumor imaging with microbubble-based ultrasound contrast agent, Sonazoid, in rabbit liver. Biol Pharm Bull 28, 972–977.
Wei, K., Crouse, L., Weiss, J., Villanueva, F., Schiller, N.B., Naqvi, T.Z., Siegel, R., Monaghan, M., Goldman, J., Aggarwal, P., Feigenbaum, H., DeMaria, A., 2003. Comparison of usefulness of dipyridamole stress myocardial contrast echocardiography to technetium-99m Sestamibi single-photon emission computed tomography for detection of coronary artery disease (PB127 multicenter phase 2 trial results). Am J Cardiol 91, 1293–1298.
WeitzSchmidt, G., Stokmaier, D., Scheel, G., Nifantev, N.E., Tuzikov, A.B., Bovin, N.V., 1996. An E-selectin binding assay based on a polyacrylamide-type glycoconjugate. Anal Biochem 238, 184–190.
Weller, G.E.R., Lu, E., Csikari, M.M., Klibanov, A.L., Fischer, D., Wagner, W.R., Villanueva, F.S., 2003. Ultrasound Imaging of acute cardiac transplant rejection with microbubbles targeted to intercellular adhesion molecule-1. Circulation 108, 218–224.
Weller, G.E.R., Villanueva, F.S., Tom, E.M., Wagner, W.R., 2005a. Targeted ultrasound contrast agents: In vitro assessment of endothelial dysfunction and multi-targeting to ICAM-1 and sialyl Lewis. Biotechnol Bioeng 92, 780–788.
Weller, G.E.R., Wong, M.K.K., Modzelewski, R.A., Lu, E.X., Klibanov, A.L., Wagner, W.R., Villanueva, F.S., 2005b. Ultrasonic imaging of tumor angiogenesis using contrast microbubbles targeted via the tumor-binding peptide arginine-arginine-leucine. Cancer Res 65, 533–539.
Wu, Y.Q., Unger, E.C., McCreery, T.P., Sweitzer, R.H., Shen, D.K., Wu, G.L., Vielhauer, M.D., 1998. Binding and lysing of blood clots using MRX-408. Invest Radiol 33, 880–885.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Klibanov, A.L. (2008). Targeted Microbubbles: Ultrasound Contrast Agents for Molecular Imaging. In: Bulte, J.W., Modo, M.M. (eds) Nanoparticles in Biomedical Imaging. Fundamental Biomedical Technologies, vol 102. Springer, New York, NY. https://doi.org/10.1007/978-0-387-72027-2_16
Download citation
DOI: https://doi.org/10.1007/978-0-387-72027-2_16
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-72026-5
Online ISBN: 978-0-387-72027-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)